- Ownership hops held
- 75
- Resolved records
- 1
An absent edge means not yet observed — never does not exist.
EXELIXIS, INC.
EXELIXIS, INC. — US company (sec:0000939767). UBO chain traced 75 hops. Every claim linked to its source.
Ownership resolves 75 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Offshore leaks
ICIJ — Panama · Paradise · PandoraThis entity is named in 1 record in the ICIJ Offshore Leaks Database — the Panama, Paradise and Pandora Papers and the Offshore Leaks investigations.
Appearing in the ICIJ data is not evidence of wrongdoing — offshore entities have many legitimate uses. Source: ICIJ Offshore Leaks Database (offshoreleaks.icij.org), surfaced as derived links with attribution under its share-alike terms, never rehosted.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
No ownership or control links resolved yet
An absent link means “not yet observed in our current sources”, not that none exists — cross-source resolution is still growing.
We flag the moment ownership, a filing or a sanctions signal lands on it — the fastest way to catch a change on a subject we hold little on today.
75-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
Everything we hold on this subject, for one price — every hop to the ultimate owner, filing history, sanctions exposure, and the asset layer (property, vessels, aircraft) — as PDF and JSON, every claim linked to its source.
Everything we hold on EXELIXIS, INC., resolved and sourced — yours to keep, no subscription.
- UBO traceDOSSIER
- Live adverse-media scan on unlockDOSSIER
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €99.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
3 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBODOSSIER
- Adverse-media & person enrichmentDOSSIER
- Full export (PDF + un-redacted JSON) & change alertsDOSSIER
People & control
28 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- CALIGAN PARTNERS LPAlso holds roles at 9 other companies
- Liquidia Corpother
- Liquidia Corpdirector
- Liquidia Corptenpercentowner
- FELDBAUM CARL BAlso holds roles at 2 other companies
- Cardiff Oncology, Inc.director
- CONNECTIVE THERAPEUTICS INCdirector
- Freire Maria CAlso holds roles at 2 other companies
- ALEXANDRIA REAL ESTATE EQUITIES, INC.director
- BIOGEN INC.director
- Garland J. ScottAlso holds roles at 10 other companies
- ALX ONCOLOGY HOLDINGS INCdirector
- Olema Pharmaceuticals, Inc.director
- Day One Biopharmaceuticals, Inc.director
- HELLER FRANCES KAlso holds roles at 3 other companies
- MONTEREY BIO ACQUISITION CORPdirector
- Larimar Therapeutics, Inc.director
- BRISTOL MYERS SQUIBB COofficer
- HEYMAN TOMAS J.Also holds roles at 5 other companies
- LEGEND BIOTECH CORPdirector
- Akero Therapeutics, Inc.director
- OptiNose, Inc.director
- JOHNSON DAVID EDWARDAlso holds roles at 9 other companies
- Liquidia Corptenpercentowner
- Liquidia Corpdirector
- Verrica Pharmaceuticals Inc.other
- KARBE FRANKAlso holds roles at 7 other companies
- Cidara Therapeutics, Inc.officer
- Phathom Pharmaceuticals, Inc.director
- BETTER THERAPEUTICS, INC.director
- MCCORMICK FRANKAlso holds roles at 5 other companies
- BridgeBio Pharma, Inc.director
- Helix Acquisition Corp. IIdirector
- Olema Pharmaceuticals, Inc.director
- PAPADOPOULOS STELIOSAlso holds roles at 9 other companies
- Ovid Therapeutics Inc.director
- SGX PHARMACEUTICALS, INC.director
- Regulus Therapeutics Inc.director
- Peterson Amy C.Also holds roles at 2 other companies
- CytomX Therapeutics, Inc.officer
- BeiGene, Ltd.officer
- POSTE GEORGEAlso holds roles at 3 other companies
- MONSANTO CO /NEW/director
- CARIS LIFE SCIENCES, INC.director
- ORCHID BIOSCIENCES INCdirector
- SCANGOS GEORGE AAlso holds roles at 7 other companies
- AGILENT TECHNOLOGIES, INC.director
- Vir Biotechnology, Inc.director
- Voyager Therapeutics, Inc.director
- Smith JulieAlso holds roles at 4 other companies
- Stoke Therapeutics, Inc.director
- AUDENTES THERAPEUTICS, INC.director
- AXONYX INCofficer
- WRIGHT JACQUELINEAlso holds roles at 2 other companies
- BECTON DICKINSON & COdirector
- nVent Electric plcdirector
- WYSZOMIERSKI JACK LAlso holds roles at 4 other companies
- XOMA Royalty Corpdirector
- SiteOne Landscape Supply, Inc.director
- ATHERSYS, INC / NEWdirector
28 parties · 0 current. Ceased and resigned records are retained as history.
Adverse media
Live scan on unlockA live GDELT news scan for this entity's name (last 18 months) runs the moment you unlock. Matches are investigative leads by name and may come back empty.
Common questions
- Who owns EXELIXIS, INC.?
- What is EXELIXIS, INC.'s risk level?
- Where does EXELIXIS, INC. appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for EXELIXIS, INC. — nothing is disclosed before that.